Foreign Currency Exchange Contracts and Hedging (Tables)

9 Months Ended

Dec. 31, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of location and amount of gains and losses related to derivatives not designated as hedging instruments reported in consolidated financial statements

The following table summarizes the effect of Non-Designated Derivative Contracts:

	Three Months Ended December 31,
	2017		2016
Location of amount recognized in income on derivative instruments	Selling, general and administrative expenses		Selling, general and administrative expenses
Amount of gain recognized in income on derivative instruments	$	211	$	4,038

	Nine Months Ended December 31,
	2017			2016
Location of amount recognized in income on derivative instruments	Selling, general and administrative expenses			Selling, general and administrative expenses
Amount of (loss) gain recognized in income on derivative instruments	$	(2,455	)	$	3,157

As of December 31, 2017, the Company had a total notional value of $62,549 for foreign currency exchange rate forward contracts, which included the following:

	Designated Derivative Contracts			Non-Designated Derivative Contracts
Notional value	$	24,347		$	38,202
Fair value recorded in other current assets	—			130
Fair value recorded in other accrued expenses	(1,827		)	(394		)

Schedule of location and amount of gains and losses related to derivatives designated as hedging instruments reported in consolidated financial statements

The following table summarizes the effect of Designated Derivative Contracts:

	Three Months Ended December 31,
	2017			2016
Amount of gain recognized in other comprehensive income (loss) on derivative instruments (effective portion)	$	108		$	2,054
Location of amount reclassified from accumulated other comprehensive loss into income (effective portion)	Net Sales			Net Sales
Amount of (loss) gain reclassified from accumulated other comprehensive loss into income (effective portion)	$	(3,914	)	$	4,294
Location of amount excluded from effectiveness testing	Selling, general and administrative expenses			Selling, general and administrative expenses
Amount of gain excluded from effectiveness testing	$	273		$	142

	Nine Months Ended December 31,
	2017			2016
Amount of (loss) gain recognized in other comprehensive income (loss) on derivative instruments (effective portion)	$	(9,682	)	$	6,957
Location of amount reclassified from accumulated other comprehensive loss into income (effective portion)	Net Sales			Net Sales
Amount of (loss) gain reclassified from accumulated other comprehensive loss into income (effective portion)	$	(6,197	)	$	5,970
Location of amount excluded from effectiveness testing	Selling, general and administrative expenses			Selling, general and administrative expenses
Amount of gain excluded from effectiveness testing	$	1,045		$	497